Viking Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · San Diego, CA
VKTX chart
What traders are saying about $VKTX
Latest postsViking Therapeutics, Inc. news
- Canaccord trims target for Viking Therapeutics stock
ad-hoc-news.de ·
- Viking Therapeutics, Inc. (VKTX) stock price, news, quote and history - Yahoo Finance
Yahoo Finance Singapore ·
- Buy, Sell or Hold LLY Stock? Key Factors to Watch Ahead of Q3 Earnings
Yahoo Finance ·
- Viking Therapeutics, Inc. (VKTX) latest stock news and headlines
Yahoo Finance Australia ·
- Viking Therapeutics, Inc. expected to post a loss of $1.07 a share - Earnings Preview
TradingView ·
- Zacks Investment Research
גלובס ·
- Should You Buy Viking Therapeutics Stock Ahead of Q3 Results?
Yahoo Finance ·
- Viking Therapeutics (VKTX) Launches SUNRISE As Investors Ask If The Stock Is Already Pricey
Simply Wall Street ·
- Can Corcept Therapeutics Stock Rally 40% After This Dip?
trefis.com ·
- Viking Therapeutics focuses on oral obesity dru...
Pluang ·
- Why Viking Therapeutics’ Oral Obesity Strategy Will Be a Make-or-Break Focus on Oct. 28
247wallst.com ·
- Viking Therapeutics sets October 28 results date for Viking Therapeutics stock
ad-hoc-news.de ·
Viking Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| Net income | -$359.6M | -$110.0M | -$85.9M | -$68.9M |
| Diluted EPS | $-3.19 | $-1.01 | $-0.91 | $-0.90 |
| Total assets (year end) | $715.7M | $908.3M | $368.5M | $168.5M |
| Cash and equivalents (year end) | $165.8M | $26.7M | $55.5M | $36.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Viking Therapeutics, Inc.
- Ticker
- VKTX (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- San Diego, CA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1607678
Frequently asked questions
What exchange is Viking Therapeutics, Inc. listed on?
Viking Therapeutics, Inc. trades on the Nasdaq under the ticker symbol VKTX.
What industry is Viking Therapeutics, Inc. in?
Viking Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Viking Therapeutics, Inc. headquartered?
Viking Therapeutics, Inc.'s business address on file with the SEC is in San Diego, CA.
When does Viking Therapeutics, Inc.'s fiscal year end?
Viking Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Viking Therapeutics, Inc. report?
Viking Therapeutics, Inc. reported $0 in revenue for calendar year 2025, according to its SEC filings.